Navigation Links
GenVault Receives Four Critical U.S. and E.U. Patent Allowances for Key Biosample Management Technologies

CARLSBAD, Calif., May 20 /PRNewswire/ -- GenVault Corporation is pleased to announce notice of allowance for four key patents in its growing portfolio. U.S. Patent Application #10/005,415, entitled "Automated Biological Sample Archive for Storage, Retrieval & Analysis of a Large Number of Samples" and European Patent Application #02776478.6, entitled "Archive & Analysis System and Method," complement the already-awarded U.S. patent U.S. Patent #7,142,987. Taken together, these allowed and awarded patents grant GenVault broad, exclusive, intellectual property coverage in support of its core business: the development and commercialization of consumables, hardware and software for the acquisition, storage and recovery of biological specimens that have been preserved in the dried solid state, to be used for the building and use as biobanks or biorepositories.

GenVault is also pleased to announce notice of allowance of the first of several key patents in its portfolio which cover novel matrices to stabilize biospecimens in the air-dried state. The allowed claims in "Stable Protein Storage and Stable Nucleic Acid Storage in Recoverable Form," U.S. Patent Application #11/137,806 and European Patent Application #05754240.9, grant GenVault broad, exclusive intellectual property coverage in support of a range of new products based on biospecimen stabilization in engineered sponge and similar materials. The company feels that this new "elastomeric" matrix offers the promise to be a replacement for filter paper, swabs and a number of other matrices for the collection, shipping and storage of biospecimens, especially in the context of public health and personalized medicine.

"GenVault continues to strengthen its leadership position in the emerging field of efficient and cost effective biosample management with an expanding patent portfolio," said David Wellis, CEO, GenVault. "Our growth and value strategy includes firmly establishing GenVault's intellectual property position which enables the company to exclusively market consumables, hardware and software solutions for the efficient transport and banking of biosamples."

About GenVault

GenVault is the global leader in providing risk free biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable, reliable and environmentally friendly alternative to traditional freezers and DNA purification systems, the company's dry-state platforms enable the extraction, preservation, recovery, and distribution of DNA at ambient temperatures. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for DNA sample management and preservation. For more information visit GenVault at


    Bret Dash, Director of Marketing
    (760) 268-5242

Available Topic Expert(s): For information on the listed expert(s), click

appropriate link.

Bret Dash

SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Shane Lyons Joins GenVault Corporation as Vice President of Sales and Marketing
2. GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2
3. GenVault Opens Japanese Subsidiary to Better Address Global Biobanking Market Growth
4. GenVault to Present at the BIOCOM Investor Conference
5. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
6. GenVault Corporation Launches GenTegra(TM) DNA
7. GenVault Expands Scientific Advisory Board
8. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
9. Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing
10. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
11. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
Post Your Comments:
(Date:12/1/2015)...  CardioCell LLC, a Stemedica Cell Technologies Inc. ... indications, intends to proceed with finalizing a Phase ... a Heart Failure Advisory Board comprising cardiology key ... members . In a recent meeting members of ... efficacy data from CardioCell,s on-going chronic heart failure ...
(Date:12/1/2015)... Frederick, MD (PRWEB) , ... December 01, 2015 ... ... management solutions provider, announces that its best selling system laboratory animal colony management ... ezColony® Cloud today, without investing in on-site IT resources., , ...
(Date:12/1/2015)... SAN FRANCISCO , Dec. 1, 2015  Symic, ... and affect the extracellular matrix (ECM), today announced that ... financing to advance the company,s pipeline, including its lead ... Lilly Ventures and includes the participation by all existing ... new funding brings the total capital raised by Symic ...
(Date:12/1/2015)... , December 1, 2015 Dr. Harry Lander , President ... serving as Chief Science Officer and recruits five ... Harry Lander , President of Regen, expands his role to ... recruits five distinguished scientists to join advisory team ... expands his role to include serving as ...
Breaking Biology Technology:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):